Last reviewed · How we verify
NCT07517692: FIX-SDM LCS
Facilitation of Information eXchange for Shared Decision Making for Lung Cancer Screening
NA trial testing FIX-SDM in Lung Cancer Screening in 120 participants. Enrolling by invitation.
1 January 2028
Quick facts
| Lead sponsor | University of Massachusetts, Worcester |
|---|---|
| Phase | NA |
| Status | ENROLLING BY INVITATION |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | screening |
| Enrollment | 120 |
| Start date | 7 April 2026 |
| Primary completion | 1 January 2028 |
| Estimated completion | 1 June 2028 |
| Sites | 1 location across United States |
Drugs / interventions tested
- FIX-SDM
- Usual Care
Conditions studied
- Lung Cancer Screening — all drugs for Lung Cancer Screening →
Sponsor
University of Massachusetts, Worcester
Who can join
Adults 50 to 77, any sex, with Lung Cancer Screening. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this pilot clinical trial is to learn whether the patient and provider support program, called FIX-SDM, helps patients and providers engage in shared decision-making for lung cancer screening during primary care visits and increases the number of patients who complete lung cancer screening. The investigators will also assess the acceptability of the support program and the feasibility of the study protocol to prepare for a future large-scale trial. The main questions this trial aims to answer are: * Does the patient and provider support increase the number of patients who complete lung cancer screening? * Does the patient and provider support help patients and health care providers engage more in shared decision-making and improve the quality of the patient's decision regarding lung cancer screening? * Is the study protocol feasible? The investigators will compare the patient and provider support program to usual care to see if the support increases the number of patients who complete lung cancer screening. Primary care provider participants will: * Receive the provider support session and educational materials, or follow usual practice * Answer a baseline survey and a follow-up survey in 6 months * Answer additional survey questions regarding the acceptability of the provider support session if they receive it Patient participants will * Receive a smoking history survey, a decision aid, and text messages about lung cancer screening prior to the primary care visit, or receive usual care * Complete the baseline survey and two follow-up surveys, one right after the primary care visit and another 3 months after the visit.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07517692
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Lung Cancer Screening
Currently open trials in the same condition.
- NCT06872723 — CPRIT: Patient Adherence to Lung Cancer Screening · recruiting
- NCT05747443 — Multilevel Interventions to Increase Adherence to Lung Cancer Screening · NA · active not recruiting
- NCT05630950 — LDCT-SC-FI Low-dose CT Screening for Lung Cancer · NA · active not recruiting
- NCT05195385 — Lung Cancer Screening With Low-dose CT Scan in Women : Implementation Study · NA · recruiting
- NCT06451029 — Prevention of Smoking Related Diseases · recruiting
Other University of Massachusetts, Worcester trials
Trials by the same sponsor.
- NCT07431528 — Dementia and Storytelling in Vietnam · NA · not yet recruiting
- NCT07060664 — Study on Outcomes of Proximal Humerus Fractures · NA · not yet recruiting
- NCT07520110 — Metformin to Attenuate Progressive Respiratory Decline in Idiopathic Pulmonary Fibrosis · Phase 3 · not yet recruiting
- NCT06100809 — Does Fatigue Coaching Improve Functioning and Fatigue in Resident Night Shifts · NA · not yet recruiting
- NCT06246539 — Impact of a Virtual Reality-based Mindfulness Program on Clinician Wellness · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07517692 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Massachusetts, Worcester
- Last refreshed: 17 April 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07517692.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing